Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -18.21%1.68B | -16.84%1.87B | -8.95%2.01B | -7.95%2.31B | -9.46%2.05B | -26.97%2.25B | -13.35%2.21B | -4.62%2.51B | -23.15%2.26B | 12.29%3.08B |
Notes receivable and accounts receivable | -16.78%1.36B | -18.09%1.59B | -16.65%1.75B | -12.58%1.63B | -23.20%1.63B | 7.52%1.94B | -6.81%2.1B | -21.62%1.87B | -1.85%2.13B | -6.83%1.8B |
-Notes receivable | -46.31%353.13M | -36.29%467.89M | -18.91%639.08M | -23.59%487.62M | -27.33%657.72M | -7.43%734.4M | -26.56%788.13M | -56.44%638.12M | -36.94%905.06M | -27.91%793.37M |
-Accounts receivable | 3.14%1.01B | -6.96%1.12B | -15.29%1.11B | -6.86%1.14B | -20.15%974.64M | 19.29%1.2B | 11.10%1.31B | 33.99%1.23B | 67.06%1.22B | 21.03%1.01B |
Other receivables (including interest and dividends) | -72.68%201.73M | 1,697.28%190.21M | 1,401.57%186.56M | 5,897.40%594.83M | 5,896.56%738.42M | -11.45%10.58M | -24.66%12.42M | -37.71%9.92M | -23.00%12.31M | 2.27%11.95M |
-Other receivable | -72.68%201.73M | ---- | 1,401.57%186.56M | ---- | 5,896.56%738.42M | ---- | -24.66%12.42M | ---- | -23.00%12.31M | ---- |
Advance payment | -2.84%197.01M | 3.08%315.49M | -25.14%183.2M | 4.12%241.36M | -24.73%202.76M | 10.56%306.06M | 4.63%244.72M | -24.67%231.81M | 3.46%269.36M | 9.21%276.84M |
Inventories | 19.88%1.99B | 39.16%2.03B | 15.45%2.08B | -5.32%1.6B | -3.92%1.66B | -23.16%1.46B | 8.01%1.8B | 7.88%1.7B | 0.23%1.73B | -1.64%1.9B |
Receivable financing | -23.63%470.75M | -48.25%366.24M | 48.23%469.99M | 2.41%535.61M | 107.23%616.43M | 37.17%707.69M | -67.25%317.06M | -21.08%523.02M | -39.08%297.46M | -50.66%515.91M |
Assets held for sale | ---- | ---- | ---- | ---- | --21.98M | ---- | ---- | ---- | ---- | ---- |
Other current assets | 143.41%228.1M | 624.51%211.02M | 94.00%180.81M | 25.76%93.19M | 17.98%93.71M | 12.10%29.13M | 488.36%93.2M | 31.49%74.1M | 120.99%79.43M | 13.83%25.98M |
Total current assets | -12.72%6.12B | -1.90%6.57B | 1.23%6.86B | 1.47%7.01B | 3.54%7.02B | -11.98%6.7B | -12.04%6.77B | -9.39%6.91B | -11.26%6.78B | -4.16%7.61B |
Non Current assets | ||||||||||
Long-term equity investment | 0.75%520.51M | -1.64%516.3M | 0.05%509.12M | -1.39%506.9M | 1.15%516.66M | 4.39%524.91M | 2.55%508.85M | 2.37%514.02M | 2.35%510.8M | 3.41%502.84M |
Fixed assets | -4.53%5.78B | ---- | -9.69%6.12B | ---- | -7.34%6.05B | ---- | 4.45%6.77B | ---- | 0.53%6.53B | ---- |
Fixed assets liquidation | -16.70%90.37M | ---- | -4.42%104.64M | ---- | -2.73%108.49M | ---- | 21.28%109.49M | ---- | -2.35%111.53M | ---- |
Constru in process | 137.40%1.9B | ---- | 118.59%1B | ---- | 35.36%800.32M | ---- | -13.67%458.15M | ---- | -18.15%591.27M | ---- |
Construction materials | --14.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16.93M | ---- |
Intangible assets | 20.97%645.01M | -1.33%609.3M | -1.38%614.48M | -2.87%598.16M | -14.30%533.2M | -1.96%617.54M | -1.47%623.06M | 6.43%615.84M | 6.48%622.18M | 7.31%629.87M |
Long deferred expense | 1,824.42%24.61M | 50.38%2.05M | 7.99%1.13M | 10.46%1.35M | -8.88%1.28M | -10.89%1.36M | -38.79%1.04M | -34.93%1.22M | -31.74%1.4M | -31.50%1.53M |
Deferred tax assets | 2.81%70.27M | 20.68%68.9M | 15.06%68.63M | 20.37%72.72M | 12.57%68.35M | 160.13%57.09M | 155.69%59.65M | 232.84%60.42M | 242.64%60.72M | -24.92%21.95M |
Usufruct assets | -7.06%24.55M | -9.97%26.48M | -8.34%29.86M | 23.22%33.42M | -8.53%26.42M | -24.93%29.41M | -22.20%32.58M | -48.42%27.12M | 45.44%28.88M | --39.18M |
Other non current assets | -14.43%101.59M | 85.50%171.86M | 89.84%211.37M | -11.82%158.14M | -25.47%118.72M | -41.17%92.65M | -34.32%111.34M | -0.80%179.35M | 75.66%159.28M | -0.38%157.49M |
Total non current assets | 11.47%9.17B | 2.32%8.92B | -0.22%8.66B | -0.10%8.53B | -4.74%8.23B | 2.77%8.72B | 2.44%8.68B | -0.04%8.53B | 1.02%8.63B | -1.49%8.48B |
Total assets | 0.34%15.29B | 0.49%15.49B | 0.42%15.51B | 0.60%15.54B | -1.10%15.24B | -4.21%15.41B | -4.45%15.45B | -4.45%15.45B | -4.78%15.41B | -2.77%16.09B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -22.70%1.31B | -29.48%1.53B | -37.44%1.4B | -27.14%1.52B | -8.55%1.7B | 17.24%2.17B | 14.11%2.24B | 6.18%2.09B | -10.75%1.86B | -27.47%1.85B |
Notes payable and accounts payable | -6.61%2.4B | -14.26%2.18B | -7.59%2.46B | -6.77%2.68B | -18.14%2.57B | -18.27%2.54B | -20.86%2.66B | -16.90%2.88B | -13.94%3.15B | -10.13%3.1B |
-Notes payable | -40.28%541.97M | -31.68%700.85M | -23.68%817.03M | -14.90%800.15M | -13.37%907.56M | -15.31%1.03B | -21.21%1.07B | -39.69%940.27M | -36.63%1.05B | -28.35%1.21B |
-Accounts payable | 11.72%1.86B | -2.44%1.47B | 3.22%1.65B | -2.82%1.88B | -20.53%1.67B | -20.16%1.51B | -20.62%1.59B | 1.78%1.94B | 4.79%2.1B | 7.33%1.89B |
Contract liabilities | -15.21%189.06M | -32.34%237.23M | -12.40%227.62M | -9.78%208.1M | -9.73%222.98M | -23.42%350.62M | -5.19%259.83M | -35.39%230.67M | -0.80%247.02M | 14.49%457.88M |
Salaries payable | 8.27%138.42M | -6.53%119.22M | -11.78%120.36M | -14.48%121.86M | -14.84%127.84M | -6.30%127.55M | -0.10%136.43M | -7.02%142.5M | -5.18%150.12M | -11.17%136.12M |
Taxs payable | -51.78%58.67M | -55.92%45.97M | 10.97%57.32M | 19.01%95.15M | 67.80%121.69M | -26.13%104.31M | -65.72%51.66M | -33.62%79.96M | -44.99%72.52M | -6.90%141.2M |
Other payable (including interest and dividends) | 12.96%130.44M | 21.99%130.37M | 34.06%139.38M | 58.61%156.32M | 17.59%115.47M | 4.25%106.87M | 7.16%103.96M | 16.76%98.55M | -7.85%98.2M | 5.01%102.52M |
-Other payable | 12.96%130.44M | ---- | 34.06%139.38M | ---- | 17.59%115.47M | ---- | 7.16%103.96M | ---- | -7.85%98.2M | ---- |
Non current liabilities due within one year | 104.64%614.05M | -16.34%251.05M | -7.87%309.87M | -41.21%231.37M | 107.49%300.06M | 111.47%300.09M | 206.86%336.34M | 5,561.53%393.57M | 1,031.38%144.62M | 942.92%141.91M |
Other current liabilities | -42.36%24.58M | -32.34%30.84M | -12.40%29.59M | -9.78%27.05M | 32.77%42.64M | -23.42%45.58M | -5.19%33.78M | -35.39%29.99M | -0.80%32.11M | 16.99%59.52M |
Total current liabilities | -6.37%4.87B | -21.27%4.52B | -18.50%4.75B | -15.10%5.04B | -9.46%5.21B | -4.22%5.74B | -5.01%5.82B | -4.14%5.94B | -10.57%5.75B | -12.78%5.99B |
Current liabilities | ||||||||||
Long term loan | 99.09%964.43M | 821.38%1.39B | 798.37%1.16B | 2,045.20%858.08M | 67.05%484.43M | -47.92%151.03M | -60.24%128.66M | -69.64%40M | 119.90%290M | 119.20%290M |
Deferred tax liabilities | 9.99%151.4M | 0.40%148.85M | 4.95%157.87M | -5.14%148.27M | -10.93%137.65M | 124.54%148.25M | 120.40%150.43M | 139.82%156.3M | 128.53%154.54M | 102.18%66.02M |
Long term deferred income | 39.81%130.91M | 7.03%93.62M | 6.25%96.75M | -1.08%89.68M | -1.15%93.64M | -14.13%87.47M | -12.96%91.06M | -15.30%90.66M | -15.20%94.72M | -14.52%101.86M |
Lease liabilities | -24.97%12.51M | -4.27%24.25M | -6.98%24.33M | 36.03%25.99M | -14.03%16.67M | -31.07%25.33M | -25.71%26.15M | -52.68%19.1M | 53.59%19.39M | --36.75M |
Total non current liabilities | 71.94%1.26B | 302.42%1.66B | 262.05%1.43B | 266.60%1.12B | 31.10%732.39M | -16.69%412.08M | -25.46%396.3M | -11.11%306.06M | 72.52%558.65M | 74.10%494.63M |
Total liabilities | 3.29%6.13B | 0.42%6.18B | -0.63%6.18B | -1.30%6.17B | -5.86%5.94B | -5.17%6.15B | -6.64%6.22B | -4.51%6.25B | -6.59%6.31B | -9.33%6.49B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%1.52B | 0.00%1.52B | 0.00%1.52B | 40.00%1.52B | 40.00%1.52B | 29.92%1.52B | 29.92%1.52B | -7.20%1.08B | -7.20%1.08B | 0.00%1.17B |
Capital reserve funds | -0.24%1.47B | -0.26%1.47B | -0.24%1.47B | -22.75%1.48B | -22.69%1.48B | -35.92%1.48B | -35.92%1.48B | -16.85%1.91B | -17.12%1.91B | 0.32%2.3B |
Surplus reserve funds | 0.00%916.53M | -0.00%916.53M | -0.00%916.53M | -0.00%916.53M | 0.00%916.53M | 1.66%916.54M | 1.66%916.54M | 1.66%916.54M | 1.66%916.53M | 6.30%901.6M |
Retained profit | -0.67%5.23B | 2.11%5.36B | 3.50%5.38B | 4.76%5.38B | 4.73%5.27B | 4.06%5.25B | 5.06%5.2B | 1.65%5.13B | 3.46%5.03B | 3.73%5.05B |
Less:Treasury stock | --89.02M | --88.66M | --86.49M | --44.7M | ---- | ---- | ---- | ---- | ---- | ---- |
Specific reserves | 1.28%93.14M | 0.50%94.6M | -7.75%94.35M | -13.15%92.35M | -14.77%91.97M | -14.59%94.13M | -3.80%102.28M | -5.61%106.34M | 6.94%107.91M | 4.42%110.21M |
Shareholders equity without minority interests | -1.37%9.14B | 0.20%9.27B | 0.91%9.29B | 2.01%9.34B | 2.46%9.27B | -2.88%9.26B | -2.30%9.21B | -3.98%9.15B | -3.09%9.05B | 2.66%9.53B |
Minority interests | -48.90%18.27M | 426.09%38.2M | 88.29%40.75M | -21.91%35.66M | -37.91%35.76M | -90.22%7.26M | -73.69%21.64M | -50.13%45.66M | -40.91%57.6M | -33.87%74.29M |
Total shareholder equity | -1.55%9.16B | 0.53%9.31B | 1.12%9.33B | 1.90%9.37B | 2.20%9.3B | -3.56%9.26B | -2.92%9.23B | -4.42%9.2B | -3.48%9.1B | 2.22%9.6B |
Total liabilityies and equity | 0.34%15.29B | 0.49%15.49B | 0.42%15.51B | 0.60%15.54B | -1.10%15.24B | -4.21%15.41B | -4.45%15.45B | -4.45%15.45B | -4.78%15.41B | -2.77%16.09B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.